| 702 |
Centers for Disease Control and Prevention |
Html |
en |
Seasonal Influenza Vaccination Coverage Among Women WhoDelivered a Live-Born Infant - 21 States and New York City, 2009-10and 2010-11 Influenza Seasons |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| influenza infection | 0.322347 |
| influenza vaccination coverage | 0.866005 |
| influenza vaccination data | 0.461318 |
| H1N1 flu shot. | 0.272803 |
| influenza vaccination postpartum | 0.44382 |
| Weighted PRAMS data | 0.288202 |
| seasonal influenza vaccination | 0.797046 |
| New York City | 0.319963 |
| vaccination coverage | 0.987757 |
| vaccination promotion strategies | 0.409116 |
| pregnant women | 0.72243 |
| higher influenza vaccination | 0.444025 |
| vaccination coverage levels | 0.378916 |
| state birth certificate | 0.263401 |
| vaccination rates | 0.341725 |
| influenza vaccine | 0.331595 |
| pregnancy | 0.349482 |
| Pregnant women experience | 0.33784 |
| median vaccination coverage | 0.419292 |
| vaccination coverage data | 0.398227 |
| live births | 0.367256 |
| live-born infant | 0.270743 |
| Indu B. Ahluwalia | 0.307812 |
| CDC PRAMS team | 0.273046 |
| high seasonal influenza | 0.347928 |
|
| PRAMS influenza supplement | 0.339169 |
| states | 0.278077 |
| postpartum women | 0.27415 |
| Immunization Practices | 0.267605 |
| Pregnancy Risk Assessment | 0.329904 |
| Advisory Committee | 0.270255 |
| recent live births | 0.26848 |
| American College | 0.270292 |
| PRAMS data | 0.300885 |
| evidence-based vaccination promotion | 0.349343 |
| state median response | 0.279631 |
| influenza season | 0.510121 |
| seasonal vaccination coverage | 0.50066 |
| influenza vaccines | 0.301695 |
| provider recommendation | 0.351103 |
| vaccination efforts | 0.331562 |
| influenza vaccination | 0.988219 |
| influenza seasons | 0.301875 |
| seasonal flu shot | 0.44074 |
| common place women | 0.288947 |
| state-specific seasonal influenza | 0.372038 |
| influenza vaccine safety | 0.328481 |
| public health efforts | 0.308462 |
| median coverage | 0.26497 |
|
CLICK HERE |
| 1260 |
Centers for Disease Control and Prevention |
Html |
en |
Notes from the Field: Outbreak of Pertussis in a School andReligious Community Averse to Health Care and Vaccinations -Columbia County, Florida, 2013 |
James Matthias, MPH1, Cristina Dusek2, P. Scott Pritchard, MPH1, Laura Rutledge2, Paula Kinchen3, Mark Lander, MS3 (Author affiliations at end of text). |
| James Matthias | 0.563178 |
| health care provider | 0.587603 |
| pertussis | 0.723021 |
| pertussis-antigen–containing vaccines | 0.542861 |
| public health departments | 0.547354 |
| large religious community | 0.575918 |
| Columbia County | 0.811559 |
| vaccine-preventable disease outbreaks | 0.535434 |
| communicable disease emergency | 0.556672 |
| cough illness | 0.70575 |
| Local public health | 0.546279 |
| case definitions | 0.645725 |
| Medical record review | 0.530769 |
| school attack rates | 0.532711 |
| Bordetella pertussis | 0.615408 |
| presumptive pertussis cases | 0.663347 |
| additional students | 0.462197 |
| P. Scott Pritchard | 0.56749 |
| Case onset dates | 0.540511 |
| household contacts | 0.541329 |
| laboratory confirmation | 0.534608 |
| pre-kindergarten students | 0.439372 |
| Mark Lander | 0.444422 |
| current guidelines | 0.543628 |
| local charter school | 0.581683 |
|
| Religious Community Averse | 0.608759 |
| Vaccinations — Columbia | 0.453511 |
| youngest students | 0.440534 |
| probable case definition | 0.569244 |
| 8th-grade students | 0.439933 |
| local health department | 0.591596 |
| Pertussis vaccine | 0.573104 |
| Kindergarten immunization records | 0.544757 |
| susceptible community members | 0.524682 |
| Florida Department | 0.753184 |
| health care | 0.910781 |
| polymerase chain reaction | 0.540646 |
| health care resources | 0.552898 |
| Paula Kinchen | 0.441215 |
| Author affiliations | 0.43964 |
| charter school students | 0.559123 |
| health care coverage | 0.582602 |
| laboratory-positive unimmunized child | 0.563071 |
| Cristina Dusek | 0.456438 |
| additional clinical details | 0.526954 |
| Territorial Epidemiologists case | 0.548773 |
| religious exemptions | 0.440503 |
| charter school | 0.676015 |
| Laura Rutledge | 0.440188 |
|
CLICK HERE |
| 4831 |
Centers for Disease Control and Prevention |
Html |
en |
Chronic disease epidemiology and control, 3rd edition [book review] |
null |
| reader | 0.227807 |
| chronic disease experts | 0.537297 |
| Matthew McKenna | 0.288783 |
| section | 0.237881 |
| salient chronic disease | 0.532865 |
| chronic disease risk | 0.556049 |
| social determinants | 0.300956 |
| better understanding | 0.27857 |
| chronic disease continuum | 0.559465 |
| future research | 0.284637 |
| public health approaches | 0.49915 |
| current knowledge | 0.284846 |
| major chronic conditions | 0.54615 |
| chronic disease control | 0.547202 |
| intrinsic value | 0.281748 |
| prevention | 0.229175 |
| chronic disease causation | 0.597552 |
| behavioral risk factors | 0.373783 |
| risk factors | 0.453525 |
| Keila Y. Torres | 0.350649 |
| evidence-based best practices | 0.355258 |
| subject matter | 0.281983 |
| public health practice | 0.382276 |
| chronic disease | 0.93803 |
| chronic diseases issues | 0.517304 |
|
| Doctoral Nursing Student | 0.340872 |
| authors | 0.227199 |
| life course | 0.366145 |
| widespread risk factors | 0.364977 |
| book | 0.26278 |
| official position | 0.276365 |
| Janet Collins | 0.285684 |
| target audience | 0.275914 |
| diverse group | 0.29345 |
| familiar terrain | 0.285816 |
| epidemiologic methods | 0.290034 |
| different people | 0.280213 |
| public health | 0.538994 |
| comprehensive overview | 0.281833 |
| public health professionals | 0.384363 |
| environmental determinants | 0.303123 |
| well-organized overview | 0.299504 |
| Drexel University | 0.284342 |
| chronic conditions | 0.586365 |
| easy reading | 0.281195 |
| readers | 0.229119 |
| major chronic diseases | 0.875958 |
| Chronic Disease Epidemiology | 0.595356 |
| neutral discussion | 0.285149 |
|
CLICK HERE |
| 9116 |
Centers for Disease Control and Prevention |
Html |
en |
Announcement: New National Health Interview SurveyOccupational Health Supplement Topic Page |
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. |
| mmwrq@cdc.gov. | 0.765203 |
| endorsement | 0.672646 |
| Human Services | 0.86616 |
| assistive technology | 0.766627 |
| National Health Interview | 0.91768 |
| prevalence rates | 0.752493 |
| sector profiles | 0.748022 |
| U.S. Department | 0.863176 |
| MMWR HTML versions | 0.856979 |
| tables | 0.643509 |
| new topic page | 0.878064 |
| electronic PDF version | 0.842691 |
| e-mail | 0.650564 |
| Occupational Health Supplement | 0.939743 |
| NIOSH | 0.674935 |
| Additional information | 0.763933 |
| Contact GPO | 0.767932 |
| commercial sources | 0.738753 |
| work-related health conditions | 0.914239 |
| occupation subgroups | 0.757687 |
| current prices | 0.735128 |
| work organization factors | 0.866528 |
| original paper copy | 0.851273 |
| additional profile | 0.753039 |
|
| appropriate attention | 0.733342 |
| employer stakeholders | 0.746268 |
| sector-level results | 0.751849 |
| sector profile | 0.74525 |
| U.S. Government Printing | 0.854823 |
| original MMWR paper | 0.852002 |
| Occupational Safety | 0.782877 |
| MMWR readers | 0.747161 |
| character translation | 0.731896 |
| additional outcomes | 0.751367 |
| pressing industry health | 0.910264 |
| industry averages | 0.758901 |
| National Occupational Research | 0.912437 |
| format errors | 0.734971 |
| subject line | 0.761514 |
| small subsamples | 0.74572 |
| typeset documents | 0.741575 |
| trade names | 0.738858 |
| subsectors | 0.639795 |
| official text | 0.730253 |
| organizational levels | 0.735814 |
| contain charts | 0.746327 |
| non-CDC sites | 0.738323 |
| electronic conversions | 0.730622 |
|
CLICK HERE |
| 11240 |
Centers for Disease Control and Prevention |
Html |
null |
CDC - Infografía "La verdad acerca del bronceado" |
El bronceado en interiores ha sido asociado a cánceres de piel como el melanoma (el tipo de cáncer de piel más mortal), el carcinoma basocelular y los cánceres de ojo (melanoma ocular). |
|
|
CLICK HERE |
| 11264 |
Centers for Disease Control and Prevention |
Html |
es |
Encuentre su registro devacunación de adulto |
Un registro de vacunación al día lo ayuda a usted y a sus médicos a saber si está protegido contra las enfermedades prevenibles con vacunas. Use estos consejos y herramientas para tener un registro de las vacunas que le han puesto. |
|
|
CLICK HERE |
| 13103 |
Centers for Disease Control and Prevention |
Html |
en |
Interim Guidance on the Use of Antiviral Medications for Treatment of Human Infections with Novel Influenza A Viruses Associated with Severe Human Disease |
Provides guidance for antiviral treatment of human infection with novel influenza A viruses associated with severe human disease; these viruses currently include H7N9 and HPAI H5N1. - CDC |
| influenza | 0.927901 |
| human influenza | 0.491448 |
| avian influenza | 0.620406 |
| severe H5N1 influenza | 0.480836 |
| uncomplicated seasonal influenza | 0.521785 |
| Influenza Laboratory | 0.451828 |
| influenza antiviral agents | 0.504779 |
| novel influenza | 0.909469 |
| infectious diseases | 0.640204 |
| severe influenza infection | 0.483803 |
| critically ill patients | 0.472981 |
| severe influenza | 0.570594 |
| oseltamivir treatment | 0.455019 |
| seasonal influenza viruses | 0.507204 |
| influenza illness duration | 0.465838 |
| CDC’s Influenza | 0.479248 |
| novel avian-origin influenza | 0.465717 |
| Clinical infectious diseases | 0.593228 |
| human novel influenza | 0.496006 |
| influenza illness onset | 0.500777 |
| influenza virus infection | 0.489517 |
| CDC Influenza Division | 0.472728 |
| Infectious Diseases Society | 0.601716 |
|
| Influenza Season | 0.462832 |
| lower respiratory tract | 0.488267 |
| influenza A virus | 0.500493 |
| New England journal | 0.454941 |
| influenza virus N1 | 0.470178 |
| acute seasonal influenza | 0.451953 |
| Influenza Antiviral Medications | 0.515297 |
| seasonal influenza | 0.609233 |
| acute uncomplicated influenza | 0.533816 |
| severe human disease | 0.477472 |
| ill influenza patients | 0.496696 |
| enterically administered oseltamivir | 0.449372 |
| influenza complications | 0.4586 |
| Influenza Study Group | 0.461123 |
| antiviral treatment | 0.585729 |
| influenza viral replication | 0.470065 |
| neuraminidase inhibitor | 0.460051 |
| Avian Influenza website | 0.4692 |
| official publication | 0.472049 |
| et al | 0.810561 |
| Avian Influenza AV | 0.451861 |
| severe disease | 0.452034 |
| oseltamivir | 0.512595 |
|
CLICK HERE |
| 13740 |
Centers for Disease Control and Prevention |
Html |
en |
Update: Shortened Interval for Postvaccination SerologicTesting of Infants Born to Hepatitis B-Infected Mothers |
Sarah Schillie, MD1; Trudy V. Murphy, MD1; Nancy Fenlon2; Stephen Ko, MD3; John W. Ward, MD1. |
| PVST | 0.45784 |
| immune globulin | 0.378062 |
| protective anti-HBs levels | 0.368743 |
| HBsAg-positive mothers | 0.715809 |
| United States | 0.415152 |
| final dose | 0.511215 |
| vaccine nonresponders | 0.402631 |
| 3-dose HepB vaccine | 0.550457 |
| primary HepB series | 0.379117 |
| Postvaccination serologic testing | 0.37256 |
| 8,105 HBsAg-negative infants born to HBsAg-positive | 0.472748 |
| Perinatal HBV infection | 0.399604 |
| late HBV infection | 0.384649 |
| immunocompetent vaccine responders | 0.444113 |
| nonresponding infants | 0.37746 |
| final vaccine dose | 0.608895 |
| complete HepB series | 0.383694 |
| final HepB vaccine | 0.447688 |
| combination vaccine | 0.411248 |
| perinatal HBV transmission | 0.389412 |
| public health | 0.404275 |
| Enhanced Perinatal Hepatitis | 0.443023 |
| infants | 0.5923 |
| initial vaccine series | 0.437028 |
|
| lower anti-HBs levels | 0.37018 |
| HepB vaccine dose | 0.527196 |
| Prevention Program | 0.368913 |
| anti-hbs levels | 0.597839 |
| Hepatitis B Prevention | 0.381957 |
| vaccine birth dose | 0.467 |
| perinatal hepatitis | 0.453041 |
| infected infants | 0.389537 |
| HepB vaccine series | 0.968792 |
| postexposure prophylaxis | 0.472727 |
| chronic HBV infection | 0.389559 |
| PVST interval | 0.367497 |
| new data | 0.370338 |
| hepatitis B-infected mothers | 0.40935 |
| HBV infection | 0.510937 |
| vaccine responders | 0.450879 |
| Vaccine efficacy | 0.415097 |
| healthy full-term infants | 0.415834 |
| vaccine response | 0.410338 |
| Trudy V. Murphy | 0.374182 |
| 4-dose HepB vaccine | 0.586144 |
| age | 0.399688 |
| CDC subject matter | 0.421111 |
|
CLICK HERE |
| 13938 |
Centers for Disease Control and Prevention |
Html |
en |
Youth Physical Activity Guidelines |
null |
| health education teachers | 0.54511 |
| partner organizations | 0.482853 |
| physical education | 0.48167 |
| CDC | 0.4179 |
| bone-strengthening physical activity | 0.564185 |
| community leaders | 0.484713 |
| Human Services | 0.502542 |
| Activity Guidelines Toolkit | 0.569265 |
| User Guide | 0.484928 |
| Physical Activity Guidelines | 0.671625 |
| Department | 0.418763 |
| PDF | 0.418839 |
| toolkit components | 0.492874 |
| children | 0.478041 |
| MB | 0.421363 |
| school | 0.415374 |
| coordinators | 0.418756 |
| muscle-strengthening physical activity | 0.56853 |
|
| daily physical activity | 0.673642 |
| youth physical activity | 0.756234 |
| overview | 0.415487 |
| adolescents | 0.514716 |
| various audiences | 0.48267 |
| strategies | 0.415888 |
| Americans | 0.418542 |
| state levels | 0.483969 |
| community-based organizations | 0.481375 |
| families | 0.415861 |
| physical activity | 0.966355 |
| regular physical activity | 0.564749 |
| examples | 0.41539 |
| schools | 0.415874 |
| support youth | 0.478967 |
| health benefits | 0.485042 |
| toolkit materials | 0.499358 |
|
CLICK HERE |
| 15269 |
Centers for Disease Control and Prevention |
Html |
en |
World Refugee Day | CDC Features |
CDC Promotes and Improves the Health of Refugees Every Day |
| public health issues | 0.633844 |
| refugees | 0.76953 |
| mental health | 0.550377 |
| current global refugee | 0.700567 |
| Brod transit center | 0.53599 |
| newly arrived refugees | 0.634023 |
| Health’s Division | 0.556105 |
| Health Systems Recovery | 0.613547 |
| United Nations Refugee | 0.735313 |
| U.S. State Department | 0.543658 |
| state health departments | 0.683986 |
| refugee settings | 0.622367 |
| refugee populations | 0.742495 |
| public health systems | 0.785453 |
| public health crises | 0.626523 |
| emergency response | 0.542314 |
| Migrant Health Branch | 0.621209 |
| specific refugee populations | 0.671829 |
| public health emergencies | 0.648254 |
| reproductive health | 0.546192 |
| Global Response Preparedness | 0.568247 |
| health education messages | 0.59866 |
| global humanitarian emergencies | 0.593352 |
| refugee health | 0.989055 |
| global public health | 0.749281 |
|
| state public health | 0.611642 |
| Domestic Program works | 0.542167 |
| ERRB Branch Chief | 0.535824 |
| United States | 0.679693 |
| Environmental Health—coordinates CDC | 0.54875 |
| Global WASH cluster | 0.558417 |
| refugee health profiles | 0.838491 |
| Refugee Health Coordinators | 0.737114 |
| World Refugee | 0.75903 |
| public health professionals | 0.610341 |
| public health | 0.997603 |
| Humanitarian Health Team | 0.620518 |
| Kakuma Refugee Camp | 0.675227 |
| Global Health Protection | 0.652607 |
| U.S. state health | 0.613648 |
| health education strategies | 0.592083 |
| Global Rapid Response | 0.562146 |
| refugee health programs | 0.738891 |
| refugee health information | 0.745867 |
| Global WASH Team | 0.574658 |
| U.S.-bound refugees | 0.580884 |
| Domestic Program | 0.617828 |
| United Nations agencies | 0.54328 |
| refugee resettlement agencies | 0.683185 |
|
CLICK HERE |